Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate AngioDynamics, Inc. before investing.

In this article, we go over a few key elements for understanding AngioDynamics, Inc.’s stock price such as:

• AngioDynamics, Inc.’s current stock price and volume
• Why AngioDynamics, Inc.’s stock price changed recently
• Upgrades and downgrades for ANGO from analysts
• ANGO’s stock price momentum as measured by its relative strength

About AngioDynamics, Inc. (ANGO)

Before we jump into AngioDynamics, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Want to learn more about AngioDynamics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about AngioDynamics, Inc..

AngioDynamics, Inc.’s Stock Price as of Market Close

As of May 28, 2025, 12:46 PM, CST, AngioDynamics, Inc.’s stock price was $10.230.

AngioDynamics, Inc. is up 5.36% from its previous closing price of $9.710.

During the last market session, AngioDynamics, Inc.’s stock traded between $9.600 and $10.360. Currently, there are approximately 40.85 million shares outstanding for AngioDynamics, Inc..

AngioDynamics, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

AngioDynamics, Inc. Stock Price History

AngioDynamics, Inc.’s (ANGO) price is currently up 10.12% so far this month.

During the month of May, AngioDynamics, Inc.’s stock price has reached a high of $10.360 and a low of $8.550.

Over the last year, AngioDynamics, Inc. has hit prices as high as $13.500 and as low as $5.470. Year to date, AngioDynamics, Inc.’s stock is up 11.68%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused AngioDynamics, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of May 27, 2025,, no analysts have changed their rating of AngioDynamics, Inc.’s stock over the last month.

Additionally, you'll want to evaluate AngioDynamics, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on AngioDynamics, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

AngioDynamics, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about AngioDynamics, Inc. (ANGO) by visiting AAII Stock Evaluator.

Relative Price Strength of AngioDynamics, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 27, 2025, AngioDynamics, Inc. has a weighted four-quarter relative price strength of 8.89%, which translates to a Momentum Score of 83 and is considered to be Very Strong.

Want to learn more about how AngioDynamics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

AngioDynamics, Inc. Stock Price: Bottom Line

As of May 28, 2025, AngioDynamics, Inc.’s stock price is $10.230, which is up 5.36% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like AngioDynamics, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.